Menu ×

HEALTHCARE & PHARMACEUTICAL

Cell Proliferation Kit Market Segmentation by Method (Colorimetry, Fluorescence, and Others); and by Application (Clinical, Industrial & Applied Science, and Stem Cell Research) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More

IN THE NEWS

  • March 2021- Merck declared that the U.S. Food and Drug Administration (FDA) accepted and granted priority review for a New Drug Application (NDA) for the hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor belzutifan. The drug is aimed at the potential treatment of patients with von Hippel-Lindau (VHL) disease-associated renal cell carcinoma (RCC).

  • January 2021- Thermo Fisher Scientific launched Gibco CTS OpTmizer Pro SFM, which is the first T-cell medium designed for allogeneic cell therapy workflows by improving donor T-cell proliferation

Global Cell Proliferation Kit Market Highlights Over 2022 - 2031

The global cell proliferation kit market is estimated to garner a large amount of revenue by growing at a CAGR of ~7% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the increasing number of patients diagnosed with cancer, and ongoing R&D activities associated with effective treatment of tumors across the world. According to the World Cancer Research Fund, there were about 18.1 million cancer cases in the world in 2020. Out of these, 9.3 million cases were in men and 8.8 million in women. Along with these, rising awareness levels regarding early assessment of viable cell count, and escalating demand for cytotoxic drugs globally are also expected to drive market growth in the near future. Furthermore, growing number of government initiatives for controlling the healthcare burden, and technological advancements in assay techniques are projected to offer lucrative opportunities to the market in the upcoming years.   

Cell Proliferation Kit Market Graph

The market is segmented by method into colorimetry, fluorescence, and others, out of which, the colorimetry segment is anticipated to hold the largest share in the global cell proliferation kit market. This can be accounted to the high cost-effectiveness and easy retrieval of throughput data provided by this method of detecting cell viability. Apart from these, wide deployment of this technique for several cellular activities such as DNA synthesis, metabolic activity and ATP production, is also predicted to boost the market segment growth in the future. Additionally, on the basis of application, the clinical segment is assessed to occupy the largest share during the forecast period owing to the increasing use of these kits by healthcare professionals to conduct accurate cell cycle analysis of cancer patients. CLICK TO DOWNLOAD SAMPLE REPORT   

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Cell Proliferation Kit Market Regional Synopsis

Regionally, the global cell proliferation kit market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in Asia Pacific is estimated to witness noteworthy growth over the forecast period on the back of the rising prevalence of cancer, and ongoing improvements in the healthcare infrastructure in the region. Moreover, the market in North America is expected to hold the largest share during the forecast period, which can be credited to the increasing number of research activities in oncology by prominent pharmaceutical companies in the region. In addition, high healthcare expenditure, and presence of well-established healthcare infrastructure are also projected to accelerate the market growth in the region in the coming years. As per the Centers for Medicare & Medicaid Services, the U.S. health care spending grew 9.7 percent in 2020, reaching USD 4.1 trillion, or USD 12,530 per person.  As a share of the nation's Gross Domestic Product, health spending accounted for 19.7 percent.

Cell Proliferation Kit Market Share Image

The global cell proliferation kit market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global cell proliferation kit market includes the following segments:

By Method

  • Colorimetry
  • Fluorescence
  • Others

By Application

  • Clinical
  • Industrial & Applied Science
  • Stem Cell Research

Growth Drivers

  • Increasing Number of Patients Diagnosed with Cancer
  • Ongoing R&D Activities Associated with Effective Treatment of Tumors

Challenges

  • Dearth of Skilled Medical Professionals in Lower Economic Regions

Top Featured Companies Dominating the Market

  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • General Electric Company
  • PerkinElmer Inc.
  • F. Hoffmann-La Roche AG
  • Biotium, Inc.
  • Mindray Medical International Limited
  • Biological Industries 

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved